Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies.

Presutti DG, D'Ascenzo F, Omedè P, Biondi-Zoccai G, Moretti C, Bollati M, Sciuto F, Lee MS, Moreno R, Bikkina M, Di Cuia M, Resmini C, Gaita F, Sheiban I.

J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):773-9. doi: 10.2459/JCM.0b013e3283619410. Review.

PMID:
23756410
2.

Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.

Resmini C, Di Cuia M, Ballocca F, D'Ascenzo F, Bollati M, Moretti C, Omedè PL, Sciuto F, Gaita F, Sheiban I.

Minerva Cardioangiol. 2012 Dec;60(6):573-80.

PMID:
23147435
3.

Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: the NINETY.

Sillano D, Resmini C, Meliga E, Boccuzzi G, Zuffi A, Barbato E, Gunn J, Price M, Gaita F, Sheiban I.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):414-21. doi: 10.1002/ccd.24406. Epub 2013 Jun 3.

PMID:
22517632
4.

Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease.

Meliga E, Fiorina C, Valgimigli M, Belli R, Gagnor A, Sheiban I, Resmini C, Tizzani E, Aranzulla T, Scrocca I, DE Benedictis M, Conte MR.

J Interv Cardiol. 2011 Dec;24(6):535-41. doi: 10.1111/j.1540-8183.2011.00666.x. Epub 2011 Oct 20.

PMID:
22010970
5.

LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.

Quinet EM, Basso MD, Halpern AR, Yates DW, Steffan RJ, Clerin V, Resmini C, Keith JC, Berrodin TJ, Feingold I, Zhong W, Hartman HB, Evans MJ, Gardell SJ, DiBlasio-Smith E, Mounts WM, LaVallie ER, Wrobel J, Nambi P, Vlasuk GP.

J Lipid Res. 2009 Dec;50(12):2358-70. doi: 10.1194/jlr.M900037-JLR200. Epub 2009 Mar 24.

6.

Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis.

Clerin V, Shih HH, Deng N, Hebert G, Resmini C, Shields KM, Feldman JL, Winkler A, Albert L, Maganti V, Wong A, Paulsen JE, Keith JC Jr, Vlasuk GP, Pittman DD.

Atherosclerosis. 2008 Nov;201(1):53-66. doi: 10.1016/j.atherosclerosis.2008.01.016. Epub 2008 Feb 21.

PMID:
18377911
7.

Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.

Bedard PW, Clerin V, Sushkova N, Tchernychev B, Antrilli T, Resmini C, Keith JC Jr, Hennan JK, Kaila N, Debernardo S, Janz K, Wang Q, Crandall DL, Schaub RG, Shaw GD, Carter LL.

J Pharmacol Exp Ther. 2008 Feb;324(2):497-506. Epub 2007 Nov 16.

PMID:
18024786
8.

Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.

Hu B, Collini M, Unwalla R, Miller C, Singhaus R, Quinet E, Savio D, Halpern A, Basso M, Keith J, Clerin V, Chen L, Resmini C, Liu QY, Feingold I, Huselton C, Azam F, Farnegardh M, Enroth C, Bonn T, Goos-Nilsson A, Wilhelmsson A, Nambi P, Wrobel J.

J Med Chem. 2006 Oct 19;49(21):6151-4.

PMID:
17034119
9.

A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps.

Clancy BM, Johnson JD, Lambert AJ, Rezvankhah S, Wong A, Resmini C, Feldman JL, Leppanen S, Pittman DD.

Bone. 2003 Jul;33(1):46-63.

PMID:
12919699
10.

[Introducing psychosomatic therapies into day care centers].

Resmini C.

Soins Psychiatr. 1996 Feb;(180):15-7. French. No abstract available.

PMID:
8715307
11.

IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.

Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF.

J Immunol. 1996 Feb 1;156(3):887-94.

PMID:
8558014
12.

Immunoglobulin isotype modulation after administration of IL-12.

Van Cleave V, Wolf S, Murray K, Wiencis A, Ketchum M, Bliss J, Haire T, Resmini C, Maylor R, Alderman E.

Adv Exp Med Biol. 1995;383:43-52.

PMID:
8644512

Supplemental Content

Loading ...
Support Center